A Human Laboratory Review Reported Greater Heart-Rate Increases With Cocaine and Smoked Marijuana Together

A historical review of controlled human laboratory studies reported that intravenous cocaine combined with smoked marijuana increased heart rate beyond either drug alone. That observation concerns a particular cardiovascular response and does not quantify an individual’s risk of a medical event.

The administration routes matter

Foltin and colleagues reviewed studies involving screened, experienced cocaine users in controlled settings. Their abstract specifically identifies intravenous cocaine and smoked marijuana for this combination finding. It does not supply a cannabis dose, THC potency, participant count or numerical heart-rate increment for that comparison. Those missing details prevent a precise estimate for another route, formulation or population.

Heart rate and blood pressure were separate outcomes

The review describes cardiovascular interactions across several drug combinations. Its abstract notes that blood-pressure responses to combinations were often comparable to one drug alone, while some heart-rate responses were larger. It does not justify assigning a particular blood-pressure effect to the cocaine–marijuana comparison. A larger pulse response also does not itself measure arrhythmia, myocardial injury or the incidence of a heart attack.

A combination can require its own assessment

Evidence about either drug alone cannot automatically predict the combined response. Nor does a heart rate near baseline exclude recent exposure: elsewhere in the review, repeated cocaine dosing was associated with returning pulse rates despite increasing blood levels. That cocaine observation is not proof of cannabis tolerance. The defensible cannabis-related conclusion remains narrower: this review reports a human heart-rate interaction under specified administration conditions. A case interpretation needs the actual co-exposure history and clinical findings, rather than inferring dose, impairment or causation from pulse alone.

Related analysis: a single-drug THC and cocaine study of speed and accuracy.

Research cited

Foltin, Fischman and Levin (1995). Cardiovascular effects of cocaine in humans: laboratory studies. Review abstract.

Spread the love


The National Black Lawyers

top 40 lawyers

civil trial law

Lawyers of Distinction

Loading...

Recent Blog Articles

Later Chemotherapy Cycles Did Not Supply an Analyzed Efficacy Replication

The final trial reported that efficacy results for cycles B and C were not analyzed because of substantial crossover. The first-cycle benefit therefore should not be presented as three separately demonstrated cycles of efficacy. Later treatment histories became mixed The study included different continuation and crossover arrangements across its phases….

Spread the love

Read Article: Later Chemotherapy Cycles Did Not Supply an Analyzed Efficacy Replication

Self-Titration Produced Different Capsule Counts in Active and Placebo Chemotherapy Arms

The chemotherapy study permitted capsule adjustment according to nausea and side effects. Active and placebo participants consequently did not take the same median number of capsules per dose. Capsule content and regimen were specified Each active capsule contained 2.5 milligrams of THC and 2.5 milligrams of CBD. Treatment was scheduled…

Spread the love

Read Article: Self-Titration Produced Different Capsule Counts in Active and Placebo Chemotherapy Arms

Patient-Rated Cannabis Symptoms and Clinician-Graded Adverse Events Gave Different Safety Views

The chemotherapy trial collected both patient-rated cannabinoid-related symptoms and clinician-graded adverse events. Their percentages should not be combined as though they used one severity definition. The assessments used different frameworks Participants completed a structured checklist including sedation, dizziness, anxiety, disorientation, hallucinations and palpitations. Clinicians used the Common Terminology Criteria for…

Spread the love

Read Article: Patient-Rated Cannabis Symptoms and Clinician-Graded Adverse Events Gave Different Safety Views

Speak with an expert today!

Contact the offices of Okorie Okorocha for professional and reliable advice which you can trust.

Call (424) 363-3347 Contact Us